AVEO PHARMACEUTICALS, INC. Quarterly Return On Equity in % from Q1 2012 to Q3 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Aveo Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q3 2022.
  • Aveo Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2022 was -81.7 %, a 22.3% increase year-over-year.
  • Aveo Pharmaceuticals, Inc. annual Return On Equity for 2021 was -92.8 %, a 14.9% increase from 2020.
  • Aveo Pharmaceuticals, Inc. annual Return On Equity for 2020 was -109 %, a 148% decline from 2019.
  • Aveo Pharmaceuticals, Inc. annual Return On Equity for 2019 was 225 %, a 1837% increase from 2018.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2022 -81.7 +23.4 +22.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 -87.8 +19 +17.8% Apr 1, 2022 Jun 30, 2022
Q1 2022 -85.3 +15.3 +15.2% Jan 1, 2022 Mar 31, 2022
Q4 2021 -92.8 +16.2 +14.9% Oct 1, 2021 Dec 31, 2021
Q3 2021 -105 -1.35 -1.3% Jul 1, 2021 Sep 30, 2021
Q2 2021 -107 -90 -536% Apr 1, 2021 Jun 30, 2021
Q1 2021 -101 -105 -2451% Jan 1, 2021 Mar 31, 2021
Q4 2020 -109 -334 -148% Oct 1, 2020 Dec 31, 2020
Q3 2020 -104 +458 +81.5% Jul 1, 2020 Sep 30, 2020
Q2 2020 -16.8 -28 -250% Apr 1, 2020 Jun 30, 2020
Q1 2020 4.28 +15.4 Jan 1, 2020 Mar 31, 2020
Q4 2019 225 +214 +1837% Oct 1, 2019 Dec 31, 2019
Q3 2019 -562 -610 -1269% Jul 1, 2019 Sep 30, 2019
Q2 2019 11.2 -50.4 -81.8% Apr 1, 2019 Jun 30, 2019
Q1 2019 -11.1 -179 -107% Jan 1, 2019 Mar 31, 2019
Q4 2018 11.6 -249 -95.5% Oct 1, 2018 Dec 31, 2018
Q3 2018 48.1 -439 -90.1% Jul 1, 2018 Sep 30, 2018
Q2 2018 61.6 -1.58K -96.3% Apr 1, 2018 Jun 30, 2018
Q1 2018 168 +925 Jan 1, 2018 Mar 31, 2018
Q4 2017 261 +803 Oct 1, 2017 Dec 31, 2017
Q3 2017 487 +773 Jul 1, 2017 Sep 30, 2017
Q2 2017 1.65K +1.75K Apr 1, 2017 Jun 30, 2017
Q1 2017 -757 -680 -895% Jan 1, 2017 Mar 31, 2017
Q4 2016 -543 -453 -505% Oct 1, 2016 Dec 31, 2016
Q3 2016 -286 -159 -125% Jul 1, 2016 Sep 30, 2016
Q2 2016 -101 +120 +54.3% Apr 1, 2016 Jun 30, 2016
Q1 2016 -76.1 +120 +61.3% Jan 1, 2016 Mar 31, 2016
Q4 2015 -89.7 +37.4 +29.4% Oct 1, 2015 Dec 31, 2015
Q3 2015 -127 -23.7 -23% Jul 1, 2015 Sep 30, 2015
Q2 2015 -221 -123 -126% Apr 1, 2015 Jun 30, 2015
Q1 2015 -196 -99.8 -103% Jan 1, 2015 Mar 31, 2015
Q4 2014 -127 -21.5 -20.4% Oct 1, 2014 Dec 31, 2014
Q3 2014 -103 -4.87 -4.95% Jul 1, 2014 Sep 30, 2014
Q2 2014 -98.1 -5.31 -5.73% Apr 1, 2014 Jun 30, 2014
Q1 2014 -96.6 -14.9 -18.2% Jan 1, 2014 Mar 31, 2014
Q4 2013 -105 -31.2 -42% Oct 1, 2013 Dec 31, 2013
Q3 2013 -98.3 -32.8 -50% Jul 1, 2013 Sep 30, 2013
Q2 2013 -92.7 -38.8 -71.9% Apr 1, 2013 Jun 30, 2013
Q1 2013 -81.7 -43.9 -116% Jan 1, 2013 Mar 31, 2013
Q4 2012 -74.3 Oct 1, 2012 Dec 31, 2012
Q3 2012 -65.6 Jul 1, 2012 Sep 30, 2012
Q2 2012 -54 Apr 1, 2012 Jun 30, 2012
Q1 2012 -37.8 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.